Peizhi Luo
Director Ejecutivo en ADAGENE INC. .
Fortuna: 22 M $ al 30/04/2024
Cargos activos de Peizhi Luo
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ADAGENE INC. | Director Ejecutivo | 01/11/2011 | - |
| Presidente | 01/02/2018 | - | |
| Director Técnico/Científico/I+D | - | - | |
| Fundador | 25/02/2011 | - |
Historial de carrera de Peizhi Luo
Antiguos cargos conocidos de Peizhi Luo.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Abmaxis, Inc.
 Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Director/Miembro de la Junta | 01/01/2000 | 06/11/2008 |
| Director Técnico/Científico/I+D | 01/01/2000 | 06/11/2008 | |
| Fundador | 01/01/2000 | 06/11/2008 | |
| Presidente | 01/01/2000 | 06/11/2008 | |
| XENCOR, INC. | Corporate Officer/Principal | 01/07/1998 | 01/08/2000 |
| MERCK & CO., INC. | Corporate Officer/Principal | - | - |
Formación de Peizhi Luo.
| The University of Chicago | Doctorate Degree |
| Peking University | Undergraduate Degree |
| Chinese Academy of Sciences | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| China | 4 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ADAGENE INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Peizhi Luo
- Experiencia